Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Theriva Biologics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +4 vs. Q2 2025
- Shares held
- 437.1K
- +146.1K (+50.2%) vs. Q2 2025
- Total value
- $177.0K
- +$50.8K (+40.2%) vs. Q2 2025
- New holders
- 8
- 5 more added
- Sold out
- 4
- 2 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $366.3K |
| Q4 2023 | 24 | $452.3K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $477.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.51M |
| Q1 2022 | 35 | $3.17M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 120,031 | $48.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 61,837 | $25.1K | 0.00% | +61,837 | New |
| Virtu Financial LLC | 36,781 | $15.0K | 0.00% | +2,286+6.6% | Added |
| Jane Street Group, LLC | 36,771 | $14.9K | 0.00% | +36,771 | New |
| Boothbay Fund Management, LLC | 35,601 | $14.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 32,899 | $13.3K | 0.00% | +15,712+91.4% | Added |
| Geode Capital Management, LLC | 28,209 | $11.4K | 0.00% | +9,608+51.7% | Added |
| Two Sigma Advisers, LP | 27,284 | $11.1K | 0.00% | +27,284 | New |
| UBS Group AG | 22,913 | $9.28K | 0.00% | +22,912+2,291,200.0% | Added |
| Vanguard Group Inc | 16,382 | $6.63K | 0.00% | +16,382 | New |
| HRT Financial LP | 10,142 | $4.00K | 0.00% | +10,142 | New |
| BlackRock, Inc. | 7,506 | $3.04K | 0.00% | −62−0.8% | Reduced |
| Advisor Group Holdings, Inc. | 444 | $172 | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 100 | $41 | 0.00% | +100 | New |
| Bank of America Corp | 81 | $32 | 0.00% | +7+9.5% | Added |
| SBI Securities Co., Ltd. | 59 | $24 | 0.00% | −1−1.7% | Reduced |
| IFP Advisors, Inc | 11 | $4 | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 2 | $1 | 0.00% | +2 | New |
| Danske Bank A/S | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $0 | 0.00% | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,018−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,818−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Pandora Wealth, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |